Transdominant activity of human immunodeficiency virus type 1 Vpr with a mutation at residue R73.
about
Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathwayThe mitochondriotoxic domain of Vpr determines HIV-1 virulenceAnalysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiaeSynthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 InhibitorNovel macromolecular inhibitors of human immunodeficiency virus-1 protease.Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell deathThe host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domainsCritical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis.Gene therapy progress and prospects: novel gene therapy approaches for AIDS.SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging.Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells: involvement of antiapoptotic BCL2 and c-IAP1 genes.Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages.Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.Inhibitory effects of HIV-2 Vpx on replication of HIV-1.
P2860
Q24530134-271C4831-A8A0-4E8E-8B59-383015F79599Q24674929-A8AF1701-AF79-4BEB-A8A8-240D7BC2DE13Q24804945-48AE93B1-520E-4253-8B51-BAED363E6D14Q28551700-0994F260-C9FB-43C9-A314-A2067AC6C89EQ33988828-B169A676-6665-494D-A0CE-19646E45B6CFQ34031619-52ABB5BE-3D7D-4822-A1D8-00117E560F00Q34106660-1922F53B-8E05-4D8B-95D5-EE96AEE4D334Q35922613-C44B17EB-9724-4553-B865-F742179099FBQ36036704-BBB997B6-67CB-4BBE-B59A-9DFC189708DBQ37384711-CE5F9A4B-EA0B-4901-82EA-EF929FCAAB0BQ38954832-66B77DCA-51AD-443D-A5BA-9DC5C3B7CD69Q39604854-F2078ECA-FA09-4C6F-81B8-BF3BB7F05883Q40198408-9895B20F-CB9E-402F-B591-B86E82B0FC3CQ40358843-F82CBDC8-116D-4488-81DC-0F1A7E390FC2Q40634933-FFBE56E8-8BB8-499C-9E53-A9F4A7A1144BQ40863490-5A508684-CFD6-48C9-80F0-5D778CA38677Q54216816-FAEEFE44-16AF-4037-A86A-71FC7643EFF0
P2860
Transdominant activity of human immunodeficiency virus type 1 Vpr with a mutation at residue R73.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Transdominant activity of huma ...... ith a mutation at residue R73.
@en
Transdominant activity of huma ...... ith a mutation at residue R73.
@nl
type
label
Transdominant activity of huma ...... ith a mutation at residue R73.
@en
Transdominant activity of huma ...... ith a mutation at residue R73.
@nl
prefLabel
Transdominant activity of huma ...... ith a mutation at residue R73.
@en
Transdominant activity of huma ...... ith a mutation at residue R73.
@nl
P2093
P2860
P1433
P1476
Transdominant activity of huma ...... ith a mutation at residue R73.
@en
P2093
A Srinivasan
B E Sawaya
J Rappaport
M Richardson
P2860
P304
P356
10.1128/JVI.74.10.4877-4881.2000
P407
P577
2000-05-01T00:00:00Z